Cargando…

Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis

Currently, the number of patients with coronavirus disease 2019 (COVID-19) has increased rapidly, but relationship between comorbidity and patients with COVID-19 still not clear. The aim was to explore whether the presence of common comorbidities increases COVID-19 patients’ risk. A literature searc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Bolin, Li, Ruobao, Lu, Zhong, Huang, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185114/ https://www.ncbi.nlm.nih.gov/pubmed/32267833 http://dx.doi.org/10.18632/aging.103000

Ejemplares similares

Does hypothyroidism increase the risk of breast cancer: evidence from a meta-analysis
por: Wang, Bolin, et al.
Publicado: (2020)

Comorbid Asthma Increased the Risk for COVID-19 Mortality in Asia: A Meta-Analysis
por: Shi, Liqin, et al.
Publicado: (2022)

Does taking an angiotensin inhibitor increase the risk for COVID-19? – a systematic review and meta-analysis
por: Ma, Zheng, et al.
Publicado: (2021)

Meta-analysis and adjusted estimation of COVID-19 case fatality risk in India and its association with the underlying comorbidities
por: Singh, Balbir B., et al.
Publicado: (2021)

Does COVID-19 Infection Increase the Risk of Diabetes? Current Evidence
por: Wong, Rachel, et al.
Publicado: (2023)

Comorbid asthma decreased the risk for COVID-19 mortality in the United Kingdom: Evidence based on a meta-analysis
por: Shi, Liqin, et al.
Publicado: (2023)

Immunotherapy or other anti-cancer treatments and risk of exacerbation and mortality in cancer patients with COVID-19: a systematic review and meta-analysis
por: Wang, Bolin, et al.
Publicado: (2020)

Incidence of cerebrovascular disease as a comorbidity in patients with COVID-19: A meta-analysis
por: Zhang, Jun, et al.
Publicado: (2020)

Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis
por: Fang, Xiaoyu, et al.
Publicado: (2020)

Which type of cancer patients are more susceptible to the SARS-COX-2: Evidence from a meta-analysis and bioinformatics analysis
por: Wang, Bolin, et al.
Publicado: (2020)

The prevalence of psychiatric comorbidities during the SARS and COVID-19 epidemics: a systematic review and meta-analysis of observational studies
por: Zhao, Yan-Jie, et al.
Publicado: (2021)

Does the Charlson comorbidity index help predict the risk of death in COVID-19 patients?
por: Comoglu, Senol, et al.
Publicado: (2022)

COVID-19: a risk factor for fatal outcomes in patients with comorbid cardiovascular disease
por: Xu, Hui, et al.
Publicado: (2020)

Does having a cat in your house increase your risk of catching COVID-19?
por: Allendorf, Valerie, et al.
Publicado: (2022)

Mortality risk of COVID-19 in elderly males with comorbidities: a multi-country study
por: Li, Guangdi, et al.
Publicado: (2020)

The Usage of Antibiotics by COVID-19 Patients with Comorbidities: The Risk of Increased Antimicrobial Resistance
por: Zeshan, Basit, et al.
Publicado: (2021)

Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors
por: Yin, Tingxuan, et al.
Publicado: (2021)

Does comorbidity increase the risk of mortality among children under 3 years of age?
por: Fischer Walker, Christa L, et al.
Publicado: (2013)

Corrigendum to “Does Comorbidity Increase the Risk of Dengue Hemorrhagic Fever and Dengue Shock Syndrome?”
por: Mahmood, Shahid, et al.
Publicado: (2017)

Does osteoarthritis modify the association between NSAID use and risk of comorbidities and adverse events?
por: Dell’Isola, Andrea, et al.
Publicado: (2022)

Risk factors of severe cases with COVID-19: a meta-analysis
por: Ou, Mingchun, et al.
Publicado: (2020)

Does COVID-19 Increase the Risk for Spontaneous Pneumothorax?
por: do Lago, Vanessa Carvalho, et al.
Publicado: (2020)

Does COVID-19 increase the risk of neuropsychiatric sequelae? Evidence from a mendelian randomization approach
por: Tirozzi, Alfonsina, et al.
Publicado: (2022)

Potential Genes Associated with COVID-19 and Comorbidity
por: Feng, Shanshan, et al.
Publicado: (2022)

Physical comorbidities increase the risk of psychiatric comorbidity in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

COVID-19 and metabolic comorbidities: An update on emerging evidences for optimal therapies
por: Hua, Shuang, et al.
Publicado: (2021)

A meta-analysis of comorbidities in COVID-19: Which diseases increase the susceptibility of SARS-CoV-2 infection?
por: Singh, Manoj Kumar, et al.
Publicado: (2021)

Unusually High Risks of COVID-19 Mortality with Age-Related Comorbidities: An Adjusted Meta-Analysis Method to Improve the Risk Assessment of Mortality Using the Comorbid Mortality Data
por: Antos, Andrew, et al.
Publicado: (2021)

Intrahepatic cholestasis of pregnancy can increase the risk of metabolic disorders: A meta-analysis
por: Zhang, Leiying, et al.
Publicado: (2022)

Vitamin D Deficiency and Comorbidities as Risk Factors of COVID-19 Infection: A Systematic Review and Meta-analysis
por: Mishra, Pinki, et al.
Publicado: (2022)

Does diabetes mellitus comorbidity increase the risk of drug-induced liver injury during tuberculosis treatment?
por: D. Freire, Ivanice, et al.
Publicado: (2023)

Machine Learning Approaches to Identify Patient Comorbidities and Symptoms That Increased Risk of Mortality in COVID-19
por: Aktar, Sakifa, et al.
Publicado: (2021)

WCN23-1238 COMORBIDITIES ASSOCIATED WITH INCREASED RISK OF DEATH IN CKD PATIENTS WITH COVID-19
por: BRAZ, B., et al.
Publicado: (2023)

Reply to "Does MAFLD really increase the severity of COVID-19?"
por: Pan, Lu, et al.
Publicado: (2021)

Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis
por: Zhao, Sizheng Steven, et al.
Publicado: (2020)

A meta-meta-analysis: Evaluation of meta-analyses published in the effectiveness of cardiovascular comorbidities on the severity of COVID-19
por: Naeini, Mehri Bemani, et al.
Publicado: (2021)

GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: Evidence from updated meta-analysis
por: Yu, Cui, et al.
Publicado: (2016)

Does dual HER-2 blockade treatment increase the risk of severe toxicities of special interests in breast cancer patients: A meta-analysis of randomized controlled trials
por: Hao, Shuai, et al.
Publicado: (2017)

Increased Thrombotic Risk in COVID-19: Evidence and Controversy
por: De Vita, Antonio, et al.
Publicado: (2023)

Cardiovascular Risk and Comorbidities in Patients with Rosacea: A Systematic Review and Meta-analysis
por: TSAI, Tsung-Yu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9btlhuh0s1ogmhik9ua8ls8kmf